AIP
STIM icon

Ameritas Investment Partners’s Neuronetics STIM Stock Holding History

Ameritas Investment Partners’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,692
Closed -$5.35K – 3321
2026
Q1 		$5.35K Hold
3,692
– – ﹤0.01% 2982
2025
Q4 		$5.09K Hold
3,692
– – ﹤0.01% 3026
2025
Q3 		$10.1K Hold
3,692
– – ﹤0.01% 2950
2025
Q2 		$12.9K Buy
+3,692
New +$14.6K ﹤0.01% 2871
2022
Q2 		– Sell
-1,958
Closed -$6K – 3224
2022
Q1 		$6K Hold
1,958
– – ﹤0.01% 2939
2021
Q4 		$9K Hold
1,958
– – ﹤0.01% 2931
2021
Q3 		$13K Hold
1,958
– – ﹤0.01% 2876
2021
Q2 		$31K Buy
+1,958
New +$27.1K ﹤0.01% 2489
2020
Q2 		– Sell
-1,051
Closed -$2K – 3130
2020
Q1 		$2K Hold
1,051
– – ﹤0.01% 2973
2019
Q4 		$5K Hold
1,051
– – ﹤0.01% 2906
2019
Q3 		$9K Hold
1,051
– – ﹤0.01% 2791
2019
Q2 		$13K Hold
1,051
– – ﹤0.01% 2696
2019
Q1 		$16K Buy
1,051
+525
+100% +$8.69K ﹤0.01% 2492
2018
Q4 		$10K Hold
526
– – ﹤0.01% 2673
2018
Q3 		$17K Buy
+526
New +$16K ﹤0.01% 2590

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ameritas Investment Partners's STIM Position: Q2 2026 in Review

Ameritas Investment Partners sold out of Neuronetics (STIM) in Q2 2026, closing a stake of 3,692 shares — an estimated $5.35K sold.

Ameritas Investment Partners first reported a position in STIM in Q3 2018 and held it in 15 quarters. The position peaked at $31K in Q2 2021. 86 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Ameritas Investment Partners reported no remaining Neuronetics position as of Q2 2026 after selling out during the quarter.
  • Ameritas Investment Partners sold 3,692 Neuronetics shares in Q2 2026, an estimated $5.35K.
  • Ameritas Investment Partners first reported a position in Neuronetics in Q3 2018 and held it in 15 quarters.
  • Ameritas Investment Partners's Neuronetics position peaked at $31K in Q2 2021.
  • 86 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.